AUC for blunted CP angle (0.97), hilar dysmorphism (0.86), cardiomegaly (0.96), reticulonodular pattern (0.91), rib fracture (0.98), scoliosis (0.98), atelectasis (0.96), calcification (0.96), consolidation (0.95), emphysema (0.96), fibrosis (0.95), nodule (0.91), opacity (0.92), pleural effusion (0.97), and pneumothorax (0.99). TAT decreased by about 40.63% from pre-qXR period to post-qXR period.
